FDA (Drugs) recall action 65690
The FDA (Drugs) publishes a recall like this one as 265 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 265 pages.
Labeling: Label Mixup: SENNOSIDES, Tablet, 8.6 mg may have potentially been mislabeled as one of the following drugs: FEXOFENADINE HCL, Tablet, 180 mg, NDC 41167412003, Pedigree: AD62834_1, EXP: 5/23/2014; TRIMETHOBENZAMIDE HCL, Capsule, 300 mg, NDC 53489037601, Pedigree: W002976, EXP: 6/11/2014; LORATADINE, Tablet, 10 mg, NDC 45802065078, Pedigree: W003253, EXP: 6/17/2014.
Labeling: Label Mixup: LEVOTHYROXINE SODIUM, Tablet, 137 mcg may have potentially been mislabeled as the following drug: ISONIAZID, Tablet, 300 mg, NDC 00555007102, Pedigree: AD60272_70, EXP: 5/22/2014.
Labeling: Label Mixup: PANTOPRAZOLE SODIUM DR, Tablet, 20 mg may be potentially mislabeled as one of the following drugs: HYOSCYAMINE SULFATE SL, Tablet, 0.125 mg, NDC 00574025001, Pedigree: AD60272_16, EXP: 5/22/2014; MULTIVITAMIN/MULTIMINERAL, Tablet, 0 mg, NDC 65162066810, Pedigree: AD73646_13, EXP: 5/30/2014.
The agency’s own wording, quoted from the enforcement report.
The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.
Aidapak Services is recalling Repaglinide 2 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Pancrelipase DR capsules because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Aspirin EC tablets because they may have been mislabeled as other medications. The repacked drugs were distributed in four western states.
Aidapak Services is recalling glyBURIDE MICRONIZED tablets because they may have been mislabeled as digoxin. The error could lead to patients receiving the wrong medication.
Aidapak Services, LLC is recalling 325 mg aspirin tablets because they may have been mislabeled as other prescription medications.
Aidapak Services is recalling Famciclovir 500 mg tablets because they may have been mislabeled as Tolterodine or Thiamine.
Aidapak Services, LLC is recalling Candesartan Cilexetil 16 mg tablets because they may have been mislabeled as Irbesartan 150 mg.
Aidapak Services, LLC is recalling Acarbose 25 mg tablets because they may be mislabeled as other prescription drugs. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling Niacin 500 mg tablets because they may have been mislabeled as Naproxen or Docusate Sodium.
Aidapak Services, LLC is recalling 500 mg Ascorbic Acid tablets that may have been mislabeled as Oxcarbazepine 150 mg.
Aidapak Services, LLC is recalling 5 mg cyclobenzaprine tablets because they may have been mislabeled as ascorbic acid or atenolol.
Aidapak Services is recalling 50 mcg selenium tablets that may be mislabeled as guaifenesin ER 600 mg.
Aidapak Services, LLC is recalling Atorvastatin Calcium 10 mg tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling Potassium Acid Phosphate tablets due to a potential label mixup with prednisone. The repacked drugs were distributed in four western states.
Aidapak Services, LLC is recalling 80 mg Atorvastatin Calcium tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services, LLC is recalling 81 mg Aspirin DR EC tablets because they may have been mislabeled as Sotalol HCl or Folic Acid.
Aidapak Services, LLC is recalling 5 mg hydrocortisone tablets because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Metoprolol Tartrate 25 mg tablets because they may have been mislabeled as Docusate Sodium 250 mg capsules.
Aidapak Services is recalling Saccharomyces Boulardii capsules because they may have been mislabeled as other prescription drugs.
Aidapak Services is recalling Atomoxetine HCL capsules because they may be mislabeled as other psychiatric medications.
Aidapak Services is recalling 1,101 chlordiazepoxide capsules because they may have been mislabeled as other medications. The affected drugs were distributed in four western states.
Aidapak Services is recalling Perphenazine 8 mg tablets that may have been mislabeled as Nifedipine 10 mg capsules.
Aidapak Services, LLC is recalling Flecaainide Acetate tablets because they may be mislabeled as Colestipol HCL Micronized.
Aidapak Services, LLC is recalling 500 mcg Cyanocobalamin tablets that were mislabeled as Sevelamer Carbonate or other drugs. The recall covers products distributed in Arizona, California, Oregon, and Washington.
Aidapak Services, LLC is recalling Dronedarone HCL 400 mg tablets because they may be mislabeled as Methylergonovine Maleate 0.2 mg.